. Overview and Strategy Powering the Immune System to Transform Lives. Vir Biotechnology, Inc. (including its subsidiaries, referred to as Vir Bio, the Company, we, our or us) is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. These diseases represent formidable challenges to human health. Under normal conditions, our immune system is naturally equipped to prote...
Q2 FY2026 — expected 2026-08-20
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-23 | 2025-12-31 | 0001628280-26-010749 | EDGAR | 85K words |
| 2025-02-27 | 2024-12-31 | 0001628280-25-008245 | EDGAR | — |
| 2024-02-26 | 2023-12-31 | 0001628280-24-006852 | EDGAR | — |
| 2023-02-28 | 2022-12-31 | 0000950170-23-005118 | EDGAR | — |
| 2022-02-28 | 2021-12-31 | 0000950170-22-002295 | EDGAR | — |
| 2021-02-25 | 2020-12-31 | 0001564590-21-008915 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001564590-20-013194 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-05 | 2026-06-30 | 0001628280-26-053549 | EDGAR | — |
| 2025-11-05 | 2025-09-30 | 0001628280-25-049694 | EDGAR | 43K words |
| 2025-08-06 | 2025-06-30 | 0001628280-25-038431 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023291 | EDGAR | — |
| 2024-11-04 | 2024-09-30 | 0001628280-24-044995 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0001628280-24-034195 | EDGAR | — |
| 2024-05-03 | 2024-03-31 | 0001628280-24-020299 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001628280-23-036702 | EDGAR | — |
| 2023-08-04 | 2023-06-30 | 0001628280-23-027527 | EDGAR | — |
| 2023-05-08 | 2023-03-31 | 0000950170-23-018789 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000950170-22-021854 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0000950170-22-016060 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-05 | 0001628280-26-053351 | EDGAR | — |
| 2026-07-24 | 0001628280-26-049499 | EDGAR | — |
| 2026-03-04 | 0001193125-26-091447 | EDGAR | 1K words |
| 2026-03-02 | 0001193125-26-084367 | EDGAR | — |
| 2026-02-26 | 0001193125-26-077416 | EDGAR | — |
| 2026-02-23 | 0001628280-26-010740 | EDGAR | — |
| 2026-01-12 | 0001628280-26-001768 | EDGAR | — |
| 2025-12-16 | 0001628280-25-057394 | EDGAR | — |
| 2025-11-05 | 0001628280-25-049561 | EDGAR | — |
| 2025-08-06 | 0001628280-25-038329 | EDGAR | — |
136 total filings indexed. 107 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001706431 |
| Ticker | VIR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.vir.bio |
| Listed | 2019-10-11 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/VIR (~200 tokens, structured JSON with cryptographic provenance)